Genmab — Februar 2017
-
jeps
afgørelsen ventes indenfor to måneder. Forven
tet, men god nyhed
-
CHMP Issues Positive Opinion Recommending DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma
Company Announcement CHMP issued positive opinion for DARZALEX for relapsed or refractory multiple myeloma Final decision from European...
GlobeNewswire News Room (globenewswire.com)
-
-
Og her på GENs site: http://ir.genmab.com/releasede
tail.cfm?ReleaseID=1014396 -
-
-
mon ikke vi ser en ordentlig omgang "warrantsalg" fra Nordeas side?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
